What it sells
Accelerate clinical trials with real-time, actionable insights
Business model breakdown
Buyer: who owns the budget?
Heads of clinical operations / program management at biotechs (testimonials from SVP Program Management and Head of Clinical Ops).
Trigger: what makes them buy now?
Manual Excel tracking and delayed CRO reporting; need real-time enrollment and site visibility across EDC, IRT, lab and vendor systems.
Workflow: what inputs become what output?
Connect EDC, RTSM/IRT, lab, safety and vendor reports into one automated dashboard; monitor site-level enrollment, forecast timelines, simulate adding/closing sites, continuous data review.
Economics: what it saves and how it charges
Tiered subscription by study and integration count; claims live dashboards in under 1 week and days-to-minutes reporting time savings.
Distribution: how it reaches customers
Demo-led sales (Book a demo / Get Started) plus self-selected tiers.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2023 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.